Lung Cancer Health Center
Select a Chapter
Latest Headlines
Erbitux Helps Treat Advanced Lung Cancer
Adding the targeted drug Erbitux to standard chemotherapy drugs significantly cuts the risk of death for advanced non-small-cell lung cancer patients -- regardless of what chemotherapy combination is used, a study shows.
Adding the targeted drug Erbitux to standard chemotherapy drugs significantly cuts the risk of death for advanced non-small-cell lung cancer patients -- regardless of what chemotherapy combination is used, a study shows.
Top Stories
Community & Resources
Top Search Terms for Lung Cancer
Lung Cancer Symptoms
One fourth of all people with lung cancer have no symptoms when the cancer
is diagnosed. These cancers are usually identified incidentally when a chest
x-ray is performed for another reason. The other three fourths of people
develop some symptoms. The symptoms are due to direct effects of the primary
tumor; to effects of metastatic tumors in other parts of the body; or to
malignant disturbances of hormones, blood, or other systems.
Symptoms of primary lung cancers include cough, coughing up blood, chest pain,
and shortness of breath.
- A new cough in a smoker or a former smoker should raise concern for lung
cancer.
- A cough that does not go away or gets worse over time should be evaluated
by a health care provider.
- Coughing up blood (hemoptysis) occurs in a significant number of people who
have lung cancer. Any amount of coughed-up blood should cause alarm.
- Chest pain is a symptom in about one fourth of people with lung cancer. The
pain is dull, aching, and persistent and may involve other structures
surrounding the lung.
- Shortness of breath usually results from a blockage in part of the lung,
collection of fluid around the lung (pleural effusion), or the spread of tumor
through the lungs.
- Wheezing or hoarseness may signal blockage or inflammation in the lungs
that may go along with cancer.
- Repeated respiratory infections, such as bronchitis or pneumonia, can be a sign of lung cancer.
